Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer S Najjary, R Mohammadzadeh, A Mokhtarzadeh, A Mohammadi, ... Gene 738, 144453, 2020 | 63 | 2020 |
Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells M Shirmohamadi, E Eghbali, S Najjary, A Mokhtarzadeh, AB Kojabad, ... Journal of cellular physiology 235 (2), 776-789, 2020 | 47 | 2020 |
siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468) F Vahidian, E Safarzadeh, A Mohammadi, S Najjary, B Mansoori, J Majidi, ... Molecular Biology Reports 47, 9541-9551, 2020 | 23 | 2020 |
Evaluating the role of microRNAs alterations in oral squamous cell carcinoma M Aali, AH Mesgarzadeh, S Najjary, HM Abdolahi, AB Kojabad, ... Gene 757, 144936, 2020 | 23 | 2020 |
miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene S Safaei, M Amini, S Najjary, A Mokhtarzadeh, N Bolandi, H Saeedi, ... Experimental and Molecular Pathology 125, 104753, 2022 | 13 | 2022 |
COVID-19 infection: concise review based on the immunological perspective P Lotfinejad, Z Asadzadeh, S Najjary, MH Somi, K Hajiasgharzadeh, ... Immunological Investigations 51 (2), 246-265, 2022 | 12 | 2022 |
Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line S Najjary, R Mohammadzadeh, B Mansoori, F Vahidian, A Mohammadi, ... Medical Oncology 38, 1-10, 2021 | 10 | 2021 |
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma Z Lotfi, S Najjary, F Lotfi, M Amini, A Baghbanzadeh, DJ Rashid, ER Asl, ... European Journal Of Pharmacology 901, 174006, 2021 | 8 | 2021 |
Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen? JWDAMM Shiva Najjary, Johan M. Kros, Willem de Koning, Disha Vadgama ... Acta Neuropathologica Communications, 2023 | 3 | 2023 |
Association of blood cell‐based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study S Najjary, JM Kros, BH Stricker, R Ruiter, Y Shuai, R Kraaij, K Van Steen, ... Cancer Medicine 13 (3), e6860, 2024 | 1 | 2024 |
Non-small cell lung cancer brain metastasis: the link between molecular mechanisms and novel therapeutic approaches S Najjary, DAM Mustafa, JM Kros Cancer Metastasis-Molecular Mechanism and Clinical Therapy, 2022 | 1 | 2022 |
Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix M Salarzaei, RLO van de Laar, PC Ewing-Graham, S Najjary, E van Esch, ... International Journal of Molecular Sciences 25 (11), 6205, 2024 | | 2024 |
Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers S Najjary, W de Koning, JM Kros, DAM Mustafa Frontiers in Immunology 14, 1305644, 2023 | | 2023 |
EP094/# 1572 Unraveling the complexities of cervical cancer: exploration of molecular mechanisms and immunological dichotomies between squamous cell carcinoma and adenocarcinoma M Salarzaei, R Van De Laar, PC Ewing-Graham, S Najjary, E Van Esch, ... International Journal of Gynecologic Cancer 33 (Suppl 4), 2023 | | 2023 |
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression S Najjary, S Safaee, A Mokhtarzadeh, M Amini, N Bolandi, N Alizadeh, ... | | 2021 |
The role of microRNA-34a in BACH1، PTEN and SIRT1 expression in T-cell acute lymphoblastic leukemia cell line (Jurkat) S Najjary, R Mohammadzadeh, B Baradaran Cellular and Molecular Research (Iranian Journal of Biology) 33 (2), 240-248, 2020 | | 2020 |